Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-7138

Muroi, C; Keller, M; Pangalu, A; Fortunati, M; Yonekawa, Y; Keller, E (2008). Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology, 20(3):188-192.

[img]PDF - Registered users only
1145Kb

Abstract

Neurogenic pulmonary edema (NPE), leading to cardiopulmonary dysfunction, is a potentially life-threatening complication in patients with aneurysmal subarachnoid hemorrhage (SAH). We sought to assess the clinical presentation and risk factors for the development of NPE after SAH. The database contained prospectively collected information on 477 patients with SAH. Baseline characteristics, clinical and radiologic severity of the bleeding, localization of the ruptured aneurysm, and clinical outcome of patients with NPE were compared with those of patients without NPE. Further, in patients with NPE, intracranial pressure, serum cardiac biomarkers, and hemodynamic parameters during the acute phase were evaluated retrospectively. The incidence of NPE was 8% (39 of 477 patients). Most patients with NPE were severely impaired and all of them presented with radiologically severe hemorrhage. The incidence of NPE was significantly higher in patients with ruptured aneurysm in the posterior circulation. Elevated intracranial pressure was found in 67%, pathologically high cardiac biomarkers in up to 83% of patients with NPE. However, no patient suffered from persistent cardiac dysfunction. Compared with patients without NPE, patients with NPE showed poor neurologic outcome (Glasgow outcome scale 1 to 3 in 25% vs.77% of patients). In conclusion, patients with NPE have a high mortality rate more likely due to their severity grade of the bleeding. Morbidity and mortality due to cardiopulmonary failure might be reduced by appropriate recognition and treatment. The awareness of and knowledge about occurrence, clinical presentation, and treatment of NPE, are essential for all those potentially confronted with patients with SAH in the acute phase.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neuroradiology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurosurgery
DDC:610 Medicine & health
Language:English
Date:July 2008
Deposited On:09 Dec 2008 17:14
Last Modified:27 Nov 2013 20:15
Publisher:Lippincott Wiliams & Wilkins
ISSN:0898-4921
Publisher DOI:10.1097/ANA.0b013e3181778156
Official URL:http://www.jnsa.com/pt/re/jneurosurganes/abstract.00008506-200807000-00005.htm;jsessionid=J2YQP23Mn4vCj0BVV5jnvg2gYG8vG9mBhBgYmbxxs2bKhh56r0hX!-1157250347!181195628!8091!-1
PubMed ID:18580349
Citations:Web of Science®. Times Cited: 28
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page